A strategic move or a ploy to arrest further shareholder wealth erosion?
08/07/24 -"The Grifols family and Brookfield have agreed to take Grifols private and should submit the bid in the coming weeks. This comes at an opportune time for the controlling shareholders since the shares ..."
Pages
53
Language
English
Published on
08/07/24
You may also be interested by these reports :
25/11/25
CureVac’s Q3 sales surpassed market expectations, driven by a one-off contribution from GSK. The operating profit benefited from the resolution of ...
25/11/25
Even though the sentiment around Novo has been extremely adverse (further exacerbated by today’s R&D development around Alzheimer’s), in our opinion, ...
21/11/25
Ever since Sandoz demerged from Novartis, the generics/biosimilars giant has been delivering on its promises, and remains well on track to achieve ...
19/11/25
AstraZeneca has been beating the street’s estimates over the last few quarters, on the back of strong growth momentum for its oncology, rare disease, ...